Albeit a rare pregnancy complication, fetal and neonatal alloimmune thrombocytopenia (FNAIT) due to anti-human platelet antigen (HPA)-1a antibodies carries a significant risk of intracranial bleeding in the fetus and newborn. Reduced birth weight is another possible complication of FNAIT. Currently, there is no specific treatment to prevent or treat FNAIT, neither exist screening programs identifying ...